< Back to previous page
Researcher
Bart De Geest
- Disciplines:Cardiology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 12
- Lipoprotein-targeted therapies for lipotoxic heart diseaseFrom1 Jan 2017 → 1 Jan 2021Funding: BOF - Doctoral projects, BOF - doctoral mandates
- High-density lipoprotein infusion therapy for heart failure with reduced ejection fraction and heart failure with preserved ejection fraction.From1 Oct 2015 → 30 Sep 2018Funding: FWO fellowships
- Therapeutic potential of high-density lipoproteins in heart failure with reduced ejection fractionFrom1 Oct 2014 → 13 Nov 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of metabolic stress on ventricular remodelling, myocardial substrate metabolism, and lipotoxicity in pressure overload-induced cardiomyopathy.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project
- The impact of lipoproteins and of saturated fat on the development of heart failure: an experimental gene transfer and dietary intervention study.From1 Oct 2013 → 30 Sep 2017Funding: BOF - Concerted Research Project from 1994
- High density lipoprotein raising gene transfer strategies. Towards technological advances and new therapeutic niches.From1 Oct 2011 → 30 Sep 2014Funding: BOF - Other initiatives
- Evaluation of new predictors of transplant vasculopathy in heart transplant recipients.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project
- The role of homocysteine in atherothrombosis revisited.From1 Oct 2009 → 29 Feb 2012Funding: FWO fellowships
- The impact of lipoprotein on stem cells.From1 Oct 2009 → 30 Sep 2015Funding: FWO fellowships
- Towards new therapeutic areas for HDL-targeted interventionsFrom1 Oct 2009 → 30 Sep 2013Funding: IWT personal funding - strategic basic research grants
Publications
1 - 10 of 91
- The metabolic syndrome in obese and non-obese subjects: a reappraisal of the syndrome X of Reaven(2023)
Authors: Bart De Geest
Pages: 1193 - 1194 - New Perspectives on Cholesterol and Lipoprotein Metabolism(2023)
Authors: Bart De Geest
- The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials(2023)
Authors: Bart De Geest
- Impact of High-Density Lipoproteins on Sepsis(2022)
Authors: Bart De Geest
- Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure(2022)
Authors: Bart De Geest
- Role of Oxidative Stress in Diabetic Cardiomyopathy(2022)
Authors: Bart De Geest
- The impact of air pollution and weather on cardiovascular events: The importance of time scale and historical air quality improvement(2022)
Authors: Bart De Geest
Pages: E28 - E29 - Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies(2021)
Authors: Bart De Geest
- Role of high-density lipoproteins in cardioprotection and in reverse remodeling: Therapeutic implications(2021)
Authors: Bart De Geest
- Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter(2021)
Authors: Bart De Geest
Pages: 1363 - 1365